dihexa 8 mg injectable human dose trial cognition 🧠 Could a tiny peptide actually help your brain form new connections? Meet Dihexa — now available OTC in NEUROgevity. Originally designed for Alzheimer's, it promotes Dihexa API | CAS 1401708-83-5

Twice Daily Protocol: Splitting the daily dose into morning and evening administrations (0.05 to 0.075 mg each) maintains more consistent tissue levels

Seeing a specialist who treats IC is very important

Most people want to avoid surgery, which they should because it has a higher risk and more complications

Status: Research phase Not FDA-approved Predominantly Eastern European literature SC injection or nasal spray Caveat: Most research originates from a single group

PLEASE NOTE: Even though initial research has demonstrated promising results, it is important to note that further clinical studies are needed to fully understand the safety, efficacy, and recommended dosage for BPC 157